🔎 Trials Near Me

Akèy › Nefrit Lupus › Illinois › Chicago

Etid klinik pou Nefrit Lupus nan Chicago, IL

9 etid pou Nefrit Lupus ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

Ap rekriteFaz 2
  • University of Chicago, Chicago
Laj 16 a 70 · Tout sèks · Mizajou Sep 17, 2026 · NCT07328581

VIBRANT: VIB4920 for Active Lupus Nephritis

Ap rekriteFaz 2
  • University of Chicago, Department of Medicine: Rheumatology, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05201469

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

Ap rekriteFaz 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
  • University of Chicago Medicine- Comer Children's, Chicago
Laj 8 a 20 · Tout sèks · Mizajou Sep 14, 2026 · NCT05538208

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Ap rekriteFaz 1/2
  • Research Site, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Sep 10, 2026 · NCT06897930

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Ap rekriteFaz 1
  • The University of Chicago Medical Center, Chicago
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Ap rekriteFaz 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Ap rekriteFaz 1/2
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Ap rekriteFaz 1/2
  • Nkarta Investigational Site, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Jun 4, 2026 · NCT06557265

Lupus Landmark Study: A Prospective Registry and Biorepository

Ap rekriteEtid obsèvasyon
  • University of Chicago, Chicago
Laj 18 a 110 · Tout sèks · Mizajou Apr 15, 2026 · NCT05934149

Etid Nefrit Lupus nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.